Whole-blood transcriptome analysis of linezolid-containing anti-tuberculosis regimens in drug-susceptible pulmonary tuberculosis
This BioProject includes whole-blood RNA sequencing data generated from patients with drug-susceptible pulmonary tuberculosis. Samples were collected at baseline before treatment initiation and after 4 weeks of anti-tuberculosis treatment. The study was designed to investigate differential transcriptomic profiles associated with linezolid-containing treatment regimens. Paired-end RNA sequencing was performed for longitudinal transcriptome analysis.